It’s Not Just Zantac — More Heartburn Drugs Pulled From Shelves Due to Potential Cancer Risk

Published Jan 10, 2020

It’s Not Just Zantac — More Heartburn Drugs Pulled From Shelves Due to Potential Cancer Risk

The products contain traces of NDMA, which has been linked to an increased risk of cancer.

NOW
PLAYING
Help Support the Amazing 10-Year-Old With a Rare Cancer Who Sold Her Art to Help With Her Medical Bills
NOW
PLAYING
Would You Buy These Potato Chips Instead of Another Snack Because They’re Pink? The Breast Cancer "Pinkwashing" Effect, Explained
NOW
PLAYING
Creativity & Help From Her Baby Girl Helped This Mom Stay 'Rock Solid' During Second Cancer, Leukemia
NOW
PLAYING
Cancer After 57 Days at Ground Zero: A Retired Firefighter Shares His 9/11 Story
NOW
PLAYING
Chemo During COVID-19: Survivors' Stories and Tips, Plus How Families Can Help
NOW
PLAYING
Continue Cancer Screenings Through COVID-19
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.